Glenmark
Pharmaceuticals Ltd closes at ₹ 409.10 with a Gain
of +0.90 % on 19-June-
2020 with formation of a Green Candle on Daily Price
Chart.
About the Company : Glenmark Pharmaceuticals is
a global pharmaceutical company. The Company is engaged in the development of
new chemical entities (NCEs) and new biological entities (NBEs).
The Company is
expected to Post Sales of ₹ 10579.90Cr & Net Profit
of ₹ 728.70 Cr in FY2020 and Sales of ₹11532.10 Cr & Net Profit of ₹833.80 Cr in FY2021 and Sales of ₹12540.90 Cr & Net Profit of ₹963.20 Cr in FY2022.
Valuations : The Company is now
Trading at X 0.9 of its Value. We have
valued the company with its expected Financial
Year 2020 earnings , which is now almost
~10 % Discount to its value & X 0.81 of its FY20201 earning with a Discount of ~ 19%
and X 0.72 of its FY20202 earning with a Discount of ~ 28%.
Book Value will increase to ₹ 230 Per Share ( ₹ 212 in FY2019 ). It
will be ₹259 in FY2021 and ₹292 in FY2022.
Why Bullish : Glenmark has introduces drug
for mild Covid patients , priced at Rs 103 a pill. ( Source : Media Report )
Margin of Safety (1Yr Bond Yield: Value>1 ) is now 1.7 ,which is attractive. its Future Price with its FY2022 earnings is ₹ 583.
Disclaimer : We are / may going to take exposure
shortly.
Join Us at Telegram #
https://t.me/TheNiftyNext
Data Source | NSE Website | Screener.In | Capital Line | Money Control |
The
author tracks economic, behavioural and corporate tends, hoping to gauge good
avenues of return based on Fundamental Valuations of Stocks, a follower of EPV
method. You can reach me/us at |
Twitter # NiftyNext1 | e-Mail :
Mail@NiftyNext.Com | Tel +91 8802230836 | Telegram # TheNiftyNext |